[
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203539"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Carboplatin/Cemiplimab/Pemetrexed Regimen"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203539",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A regimen consisting of carboplatin, cemiplimab and pemetrexed that may be used in the treatment of non-small cell lung cancer (NSCLC)."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C63360",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C63360",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63360",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63360",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C20354"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "NAIP Gene"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C20354",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "This gene is involved in the modification of spinal muscular atrophy. NAIP transcripts may be involved in chemotherapeutic resistance mechanisms."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C20938",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C20938",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C20938",
      "http://purl.obolibrary.org/obo/NCIT_C20347",
      "http://purl.obolibrary.org/obo/NCIT_C20462",
      "http://purl.obolibrary.org/obo/NCIT_C16612"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C20938",
      "http://purl.obolibrary.org/obo/NCIT_C20347",
      "http://purl.obolibrary.org/obo/NCIT_C20462",
      "http://purl.obolibrary.org/obo/NCIT_C16612"
    ],
    "hasDirectChildren": true,
    "numDescendants": 1,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 1,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203540"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Cisplatin/Cemiplimab/Pemetrexed Regimen"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203540",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A regimen consisting of cisplatin, cemiplimab and pemetrexed that may be used in the treatment of non-small cell lung cancer (NSCLC)."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C63360",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C63360",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63360",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63360",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203541"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Cladribine/High-dose Cytarabine/Idarubicin/Filgrastim Regimen"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203541",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A regimen consisting of cladribine, high-dose cytarabine, idarubicin and filgrastim (G-CSF) that can be used for the treatment of acute myeloid leukemia (AML)."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C63589",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C63589",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63589",
      "http://purl.obolibrary.org/obo/NCIT_C159872",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218",
      "http://purl.obolibrary.org/obo/NCIT_C173974",
      "http://purl.obolibrary.org/obo/NCIT_C186724",
      "http://purl.obolibrary.org/obo/NCIT_C186720"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63589",
      "http://purl.obolibrary.org/obo/NCIT_C159872",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218",
      "http://purl.obolibrary.org/obo/NCIT_C173974",
      "http://purl.obolibrary.org/obo/NCIT_C186724",
      "http://purl.obolibrary.org/obo/NCIT_C186720"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203542"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Clofarabine/High-dose Cytarabine Regimen"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203542",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A regimen consisting of clofarabine and high-dose cytarabine that can be used for the treatment of acute myeloid leukemia (AML)."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C63589",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C63589",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63589",
      "http://purl.obolibrary.org/obo/NCIT_C159872",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218",
      "http://purl.obolibrary.org/obo/NCIT_C173974",
      "http://purl.obolibrary.org/obo/NCIT_C186724",
      "http://purl.obolibrary.org/obo/NCIT_C186720"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63589",
      "http://purl.obolibrary.org/obo/NCIT_C159872",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218",
      "http://purl.obolibrary.org/obo/NCIT_C173974",
      "http://purl.obolibrary.org/obo/NCIT_C186724",
      "http://purl.obolibrary.org/obo/NCIT_C186720"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203543"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Clofarabine Regimen"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203543",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A regimen consisting of clofarabine that can be used for the treatment of acute lymphoblastic leukemia (ALL)."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C63588",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C63588",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63588",
      "http://purl.obolibrary.org/obo/NCIT_C173974",
      "http://purl.obolibrary.org/obo/NCIT_C186724",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218",
      "http://purl.obolibrary.org/obo/NCIT_C186719"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63588",
      "http://purl.obolibrary.org/obo/NCIT_C173974",
      "http://purl.obolibrary.org/obo/NCIT_C186724",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218",
      "http://purl.obolibrary.org/obo/NCIT_C186719"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203544"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Topical Clobetasol/Mechlorethamine Regimen"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203544",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A regimen consisting of topical clobetasol and mechlorethamine that can be used for the treatment of primary cutaneous B-cell lymphoma."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C63442",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C63442",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63442",
      "http://purl.obolibrary.org/obo/NCIT_C186719",
      "http://purl.obolibrary.org/obo/NCIT_C186724",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63442",
      "http://purl.obolibrary.org/obo/NCIT_C186719",
      "http://purl.obolibrary.org/obo/NCIT_C186724",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203545"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "CAPOX-Pembrolizumab-Trastuzumab Regimen"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203545",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A regimen consisting of capecitabine, oxaliplatin, pembrolizumab and trastuzumab that may be used in the treatment of esophageal and esophagogastric junction and gastric cancers."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C63361",
      "http://purl.obolibrary.org/obo/NCIT_C63719"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C63361",
      "http://purl.obolibrary.org/obo/NCIT_C63719"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63361",
      "http://purl.obolibrary.org/obo/NCIT_C203470",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218",
      "http://purl.obolibrary.org/obo/NCIT_C63719"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63361",
      "http://purl.obolibrary.org/obo/NCIT_C203470",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218",
      "http://purl.obolibrary.org/obo/NCIT_C63719"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203546"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Topical Clobetasol Regimen"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203546",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A regimen consisting of topical clobetasol that can be used for the treatment of primary cutaneous CD30+ T-cell lymphoproliferative disorders and mycosis fungoides/Sezary syndrome."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C63442",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C63442",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63442",
      "http://purl.obolibrary.org/obo/NCIT_C186719",
      "http://purl.obolibrary.org/obo/NCIT_C186724",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C63442",
      "http://purl.obolibrary.org/obo/NCIT_C186719",
      "http://purl.obolibrary.org/obo/NCIT_C186724",
      "http://purl.obolibrary.org/obo/NCIT_C62634",
      "http://purl.obolibrary.org/obo/NCIT_C12218"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C20355"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "BIRC2 Gene"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C20355",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "This gene is a potent inhibitor of apoptosis and plays an important role in apoptotic signal transduction."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C133710",
      "http://purl.obolibrary.org/obo/NCIT_C20938"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C133710",
      "http://purl.obolibrary.org/obo/NCIT_C20938"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C133710",
      "http://purl.obolibrary.org/obo/NCIT_C25870",
      "http://purl.obolibrary.org/obo/NCIT_C21281",
      "http://purl.obolibrary.org/obo/NCIT_C16612",
      "http://purl.obolibrary.org/obo/NCIT_C20938",
      "http://purl.obolibrary.org/obo/NCIT_C20347",
      "http://purl.obolibrary.org/obo/NCIT_C20462"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C133710",
      "http://purl.obolibrary.org/obo/NCIT_C25870",
      "http://purl.obolibrary.org/obo/NCIT_C21281",
      "http://purl.obolibrary.org/obo/NCIT_C16612",
      "http://purl.obolibrary.org/obo/NCIT_C20938",
      "http://purl.obolibrary.org/obo/NCIT_C20347",
      "http://purl.obolibrary.org/obo/NCIT_C20462"
    ],
    "hasDirectChildren": true,
    "numDescendants": 1,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 1,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203557"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Treatment Arm for COG ACNS0331 Comparison of Radiation Therapy Regimens in Combination with Chemotherapy in Treating Young Patients with Newly Diagnosed Standard-Risk Medulloblastoma"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203557",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A treatment arm associated with a phase III Children's Oncology Group trial (ACNS0331) exam the efficacy and safety of reduced-dose and reduced-volume radiotherapy with chemotherapy to treat young patients newly-diagnosed with average-risk medulloblastoma. (Michalski JM, et al. J Clin Oncol. 2021 Aug 20;39(24):2685-2697)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C15538",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C15538",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": true,
    "numDescendants": 6,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 6,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203558"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Treatment Arm for COG ACNS0332 Chemotherapy and Radiation Therapy in Treating Young Patients with Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/ PNET"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203558",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A treatment arm associated with a phase III Children’s Oncology Group trial (ACNS0332) examining if therapy intensification with carboplatin as a radiosensitizer or isotretinoin as a proapoptotic agent increases long term event-free survival in children with high-risk medulloblastoma. (Leary SES, et al. JAMA Oncol. 2021 Sep 1;7(9):1313-1321.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C15538",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C15538",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": true,
    "numDescendants": 4,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 4,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203559"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Treatment Arm for COG ACNS0333 Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients with Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203559",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A treatment arm associated with a phase III Children’s Oncology Group trial (ACNS0333) examining the efficacy and safety of intensive postoperative chemotherapy and focal radiation to treat young patients with atypical teratoid/rhabdoid tumor. (Reddy AT, et al. J Clin Oncol. 2020 Apr 10;38(11):1175-1185.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C15538",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C15538",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": true,
    "numDescendants": 2,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 2,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C20356"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "BIRC3 Gene"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C20356",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "This anti-apoptotic gene regulates apoptotic activity. BIRC3 gene promotes tumor cell survival."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C133710",
      "http://purl.obolibrary.org/obo/NCIT_C20938"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C133710",
      "http://purl.obolibrary.org/obo/NCIT_C20938"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C133710",
      "http://purl.obolibrary.org/obo/NCIT_C25870",
      "http://purl.obolibrary.org/obo/NCIT_C21281",
      "http://purl.obolibrary.org/obo/NCIT_C16612",
      "http://purl.obolibrary.org/obo/NCIT_C20938",
      "http://purl.obolibrary.org/obo/NCIT_C20347",
      "http://purl.obolibrary.org/obo/NCIT_C20462"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C133710",
      "http://purl.obolibrary.org/obo/NCIT_C25870",
      "http://purl.obolibrary.org/obo/NCIT_C21281",
      "http://purl.obolibrary.org/obo/NCIT_C16612",
      "http://purl.obolibrary.org/obo/NCIT_C20938",
      "http://purl.obolibrary.org/obo/NCIT_C20347",
      "http://purl.obolibrary.org/obo/NCIT_C20462"
    ],
    "hasDirectChildren": true,
    "numDescendants": 1,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 1,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203560"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Treatment Arm for COG ACNS0334 Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients with Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203560",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A treatment arm associated with a phase III Children’s Oncology Group trial (ACNS0334) to establish if intensive chemotherapy plus high-dose methotrexate and peripheral blood stem cell rescue results in a higher complete response rate then the same regimen without methotrexate for treatment of infants with high risk primitive neuroectodermal tumors or high-risk medulloblastoma. (Lafay-Cousin L, et al. Cancers (Basel). 2022 Feb 7;14(3):837.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C15538",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C15538",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": true,
    "numDescendants": 2,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 2,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203561"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Treatment Arm for EURO-E.W.I.N.G.99 Combination Chemotherapy with or without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients with Ewing's Sarcoma"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203561",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A treatment arm associated with a phase III of the EURO-E.W.I.N.G.99 trial to examine the efficacy of various high-dose chemotherapy regimens with or without radiation therapy and/or surgery in treating Ewing's sarcoma. (Dirksen U, et al. J Clin Oncol. 2019 Dec 1;37(34):3192-3202. Le Deley MC, et al. J Clin Oncol. 2014 Aug 10;32(23):2440-8.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C15538",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C15538",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": true,
    "numDescendants": 7,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 7,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203562"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "ACNS0331 Arm I Includes 3-7 Years of Age, LDCSI, IFRT"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203562",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients 3-7 years of age randomized with the following course sequence: 1) Lowered dose craniospinal irradiation (LDCSI), 2) Involved-field radiation therapy (IFRT) boost. (Michalski JM, et al.  J Clin Oncol. 2021 Aug 20;39(24):2685-2697.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203557",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203557",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203557",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203557",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203563"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "ACNS0331 Arm II Includes 3-7 Years of Age, LDCSI, PFRT"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203563",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients 3-7 years of age randomized with the following course sequence: 1) Lowered dose craniospinal irradiation (LDCSI), 2) Whole posterior fossa radiation therapy (PFRT) boost. (Michalski JM, et al.  J Clin Oncol. 2021 Aug 20;39(24):2685-2697.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203557",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203557",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203557",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203557",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203564"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "ACNS0331 Arm III Includes 3-7 Years of Age, SDCSI, IFRT"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203564",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients 3-7 years of age randomized with the following course sequence: 1) Standard dose craniospinal irradiation (SDCSI) 2) Involved-field radiation therapy (IFRT) boost. (Michalski JM, et al.  J Clin Oncol. 2021 Aug 20;39(24):2685-2697.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203557",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203557",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203557",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203557",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203565"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "ACNS0331 Arm IV Includes 3-7 Years of Age, SDCSI, PFRT"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203565",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients 3-7 years of age randomized with the following course sequence: 1) Standard dose craniospinal irradiation (SDCSI) 2) Whole posterior fossa radiation therapy (PFRT) boost. (Michalski JM, et al.  J Clin Oncol. 2021 Aug 20;39(24):2685-2697.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203557",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203557",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203557",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203557",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203566"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "ACNS0331 Arm V Includes 8-21 Years of Age, SDCSI, IFRT"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203566",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients 8-21 years of age randomized with the following course sequence: 1) Standard dose craniospinal irradiation (SDCSI) 2) Involved-field radiation therapy (IFRT) boost. (Michalski JM, et al.  J Clin Oncol. 2021 Aug 20;39(24):2685-2697.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203557",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203557",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203557",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203557",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203567"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "ACNS0331 Arm VI Includes 8-21 Years of Age, SDCSI, PFRT"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203567",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients 8-21 years of age randomized with the following course sequence: 1) Standard dose craniospinal irradiation (SDCSI) 2) Whole posterior fossa radiation therapy (PFRT) boost. (Michalski JM, et al.  J Clin Oncol. 2021 Aug 20;39(24):2685-2697.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203557",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203557",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203557",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203557",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203568"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "ACNS0332 Arm A"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203568",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients randomized with the following course sequence: 1) Chemoradiotherapy: Patients undergo radiation therapy once daily (QD) five days a week for 6 weeks. Patients also receive vincristine sulfate intravenously (IV) over 1 minute once weekly for 6 weeks. Six weeks after completion of chemoradiotherapy, patients proceed to maintenance therapy, 2) Maintenance Therapy: Patients receive cisplatin IV over 6 hours on day 1, vincristine sulfate IV over 1 minute on days 1 and 8, and cyclophosphamide IV over 1 hour on days 2 and 3. Patients also receive filgrastim subcutaneously (SC) or IV beginning on day 4 and continuing until blood counts recover (at least 10 days). Treatment repeats every 28 days for a total of 6 courses in the absence of disease progression or unacceptable toxicity. (Leary SES, et al. JAMA Oncol. 2021 Sep 1;7(9):1313-1321.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203558",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203558",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203558",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203558",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203569"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "ACNS0332 Arm B Includes Carboplatin"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203569",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients randomized with the following course sequence: 1) Chemoradiotherapy: Patients receive vincristine sulfate and undergo radiation therapy as in Arm I. Patients also receive carboplatin intravenously (IV) over 15 minutes on each day of radiation therapy. Six weeks after completion of chemoradiotherapy, patients proceed to maintenance therapy, 2) Maintenance Therapy: Patients receive maintenance therapy as in Arm I. (Leary SES, et al. JAMA Oncol. 2021 Sep 1;7(9):1313-1321.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203558",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203558",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203558",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203558",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C20357"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "XIAP Gene"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C20357",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "This gene is involved in apoptotic regulation through caspase interaction."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C133710",
      "http://purl.obolibrary.org/obo/NCIT_C20938"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C133710",
      "http://purl.obolibrary.org/obo/NCIT_C20938"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C133710",
      "http://purl.obolibrary.org/obo/NCIT_C25870",
      "http://purl.obolibrary.org/obo/NCIT_C21281",
      "http://purl.obolibrary.org/obo/NCIT_C16612",
      "http://purl.obolibrary.org/obo/NCIT_C20938",
      "http://purl.obolibrary.org/obo/NCIT_C20347",
      "http://purl.obolibrary.org/obo/NCIT_C20462"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C133710",
      "http://purl.obolibrary.org/obo/NCIT_C25870",
      "http://purl.obolibrary.org/obo/NCIT_C21281",
      "http://purl.obolibrary.org/obo/NCIT_C16612",
      "http://purl.obolibrary.org/obo/NCIT_C20938",
      "http://purl.obolibrary.org/obo/NCIT_C20347",
      "http://purl.obolibrary.org/obo/NCIT_C20462"
    ],
    "hasDirectChildren": true,
    "numDescendants": 1,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 1,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203570"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "ACNS0332 Arm C Includes Isotretinoin"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203570",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients randomized with the following course sequence: 1) Chemoradiotherapy: Patients undergo chemoradiotherapy as in Arm I. Six weeks after completion of chemoradiotherapy, patients proceed to maintenance therapy, 2) Maintenance Therapy: Patients receive isotretinoin orally (PO) twice daily (BID) on day 1 and days 16-28 and cisplatin, vincristine sulfate, cyclophosphamide, and filgrastim as in Arm I maintenance therapy. Treatment repeats every 28 days for a total of 6 courses in the absence of disease progression or unacceptable toxicity. Patients then proceed to continuation therapy, 3) Continuation Therapy: Patients receive isotretinoin PO BID on days 15-28 every 28 days for up to 6 courses in the absence of disease progression or unacceptable toxicity. (Leary SES, et al. JAMA Oncol. 2021 Sep 1;7(9):1313-1321.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203558",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203558",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203558",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203558",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203571"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "ACNS0332 Arm D Includes Carboplatin and Isotretinoin"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203571",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients randomized with the following course sequence: 1) Chemoradiotherapy: Patients undergo chemoradiotherapy as in Arm II. Six weeks after completion of chemoradiotherapy, patients proceed to maintenance therapy, 2) Maintenance Therapy: Patients receive maintenance therapy as in Arm III. Patients then proceed to continuation therapy, 3) Continuation Therapy: Patients receive continuation therapy as in Arm III. (Leary SES, et al. JAMA Oncol. 2021 Sep 1;7(9):1313-1321.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203558",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203558",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203558",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203558",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203572"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "ACNS0333 Arm I Includes Chemotherapy, Autologous PBSC, 3D-CRT"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203572",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients received treatment in the following courses sequence: 1) Patients receive vincristine intravenously (IV) on days 1, 8, and 15; high-dose methotrexate IV on day 1; leucovorin calcium orally or IV; etoposide IV on days 4, 5, and 6; cyclophosphamide IV on days 4 and 5; cisplatin IV on day 6, and G-CSF IV or SC on day 7 until ANC recovers (Chemotherapy), 2) Within 2-6 weeks after induction therapy or radiation therapy, patients receive high-dose carboplatin IV and high-dose thiotepa IV on days 1 and 2 and undergo autologous peripheral blood stem cells (PBSC) rescue on approximately day 4, 3) After consolidation therapy, patients undergo 3D-CRT to the brain (and the spine if needed) 5 days a week for 5-6 weeks. (Reddy AT, et al. J Clin Oncol. 2020 Oct 1;38(28):3353-3354.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203559",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203559",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203559",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203559",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203573"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "ACNS0333 Arm II Includes Chemotherapy, 3D-CRT, Autologous PBSC"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203573",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients received treatment in the following courses sequence: 1) Chemotherapy: Patients receive vincristine intravenously (IV) on days 1, 8, and 15; high-dose methotrexate IV on day 1; leucovorin calcium orally or IV; etoposide IV on days 4, 5, and 6; cyclophosphamide IV on days 4 and 5; cisplatin IV on day 6, and G-CSF IV or SC on day 7 until ANC recovers, 2) Patients undergo 3D-CRT to the brain (and the spine if needed) 5 days a week for 5-6 weeks, 3) Within 2-6 weeks after completion of radiation therapy, patients receive high-dose carboplatin IV and high-dose thiotepa IV on days 1 and 2 and undergo autologous peripheral blood stem cells (PBSC) rescue on approximately day 4. Patients also receive G-CSF IV or SC once daily until ANC recovers. Treatment repeats every 28 days for 3 courses in the absence of disease progression or unacceptable toxicity. (Reddy AT, et al. J Clin Oncol. 2020 Oct 1;38(28):3353-3354.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203559",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203559",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203559",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203559",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203574"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "ACNS0334 Arm A Includes Induction Plus Consolidation Chemotherapy, Autologous PBSC"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203574",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients randomized with the following course sequence: 1) Induction: Patients receive vincristine sulfate intravenously (IV) on days 1, 8, and 15; etoposide IV over 1 hour on days 1-3; cyclophosphamide IV over 1 hour on days 1 and 2; cisplatin IV over 6 hours on day 3. Treatment repeats every 3 weeks for 3 courses, 2) Consolidation Chemotherapy: Patients receive consolidation therapy comprising carboplatin IV over 2 hours and thiotepa IV over 2 hours on days 1 and 2 and filgrastim (G-CSF) IV or SC beginning on day 5 and continuing until blood counts recover. 3) Patients also receive autologous PBSC IV on day 4. Treatment repeats every 4 weeks for 3 courses in the absence of disease progression or unacceptable toxicity. (Lafay-Cousin L, et al. Cancers (Basel). 2022 Feb 7;14(3):837.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203560",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203560",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203560",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203560",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203575"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "ACNS0334 Arm B Includes Induction Plus Consolidation Chemotherapy, Autologous PBSC"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203575",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients randomized with the following course sequence: 1) Induction: Patients receive vincristine sulfate intravenously (IV)  on days 1, 8, and 15; high-dose methotrexate IV over 4 hours on day 1; and leucovorin calcium IV or orally every 6 hours beginning on day 2 and continuing until methotrexate levels are in a safe range. Patients then receive etoposide IV over 1 hour on approximately days 4, 5, and 6, cyclophosphamide IV over 1 hour on approximately days 4 and 5, and cisplatin IV over 6 hours on approximately day 6. Treatment repeats every 3 weeks for 3 courses, 2) Consolidation Chemotherapy: Patients receive consolidation therapy comprising carboplatin IV over 2 hours and thiotepa IV over 2 hours on days 1 and 2 and filgrastim (G-CSF) IV or SC beginning on day 5 and continuing until blood counts recover, 3) Patients also receive autologous PBSC IV on day 4. Treatment repeats every 4 weeks for 3 courses in the absence of disease progression or unacceptable toxicity. (Lafay-Cousin L, et al. Cancers (Basel). 2022 Feb 7;14(3):837.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203560",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203560",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203560",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203560",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203576"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "EE99 Not Randomized"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203576",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients are not randomized for treatment. (Dirksen U, et al. J Clin Oncol. 2019 Dec 1;37(34):3192-3202. Le Deley MC, et al. J Clin Oncol. 2014 Aug 10;32(23):2440-8.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203561",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203561",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203561",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203561",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203577"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "EE99 R1-VAC"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203577",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients randomized with the following course sequence: 1) Group 1: Vincristine, dactinomycin and cyclophosphamide (VAC) (Dirksen U, et al. J Clin Oncol. 2019 Dec 1;37(34):3192-3202. Le Deley MC, et al. J Clin Oncol. 2014 Aug 10;32(23):2440-8.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203561",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203561",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203561",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203561",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203578"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "EE99 R1-VAI"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203578",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients randomized with the following course sequence: 1) Group 1: Vincristine, dactinomycin, ifosfamide (VAI) (Dirksen U, et al. J Clin Oncol. 2019 Dec 1;37(34):3192-3202. Le Deley MC, et al. J Clin Oncol. 2014 Aug 10;32(23):2440-8.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203561",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203561",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203561",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203561",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203579"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "EE99 R2Loc-BuMel"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203579",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients randomized with the following course sequence: 1) Group 2 localized disease: High-dose busulfan and melphalan (Bu-Mel) (Dirksen U, et al. J Clin Oncol. 2019 Dec 1;37(34):3192-3202. Le Deley MC, et al. J Clin Oncol. 2014 Aug 10;32(23):2440-8.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203561",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203561",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203561",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203561",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C20358"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "APAF1 Gene"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C20358",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "This gene is involved in pro-apoptotic regulation through caspase interaction."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C20348",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C20348",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C20348",
      "http://purl.obolibrary.org/obo/NCIT_C20462",
      "http://purl.obolibrary.org/obo/NCIT_C16612"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C20348",
      "http://purl.obolibrary.org/obo/NCIT_C20462",
      "http://purl.obolibrary.org/obo/NCIT_C16612"
    ],
    "hasDirectChildren": true,
    "numDescendants": 1,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 1,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203580"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "EE99 R2Loc-VAI"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203580",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients randomized with the following course sequence: 1) Group 2 localized disease: Vincristine, dactinomycin, ifosfamide (VAI) (Dirksen U, et al. J Clin Oncol. 2019 Dec 1;37(34):3192-3202. Le Deley MC, et al. J Clin Oncol. 2014 Aug 10;32(23):2440-8.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203561",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203561",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203561",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203561",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203581"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "EE99 R2Pulm-BuMel"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203581",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients randomized with the following course sequence: 1) Group 2 pulmonary metastases disease: High-dose busulfan and melphalan (Bu-Mel) (Dirksen U, et al. J Clin Oncol. 2019 Dec 1;37(34):3192-3202. Le Deley MC, et al. J Clin Oncol. 2014 Aug 10;32(23):2440-8.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203561",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203561",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203561",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203561",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203582"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "EE99 R2Pulm-VAI Plus Lung RT"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203582",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Patients randomized with the following course sequence: 1) Group 2 pulmonary metastases disease: Vincristine, dactinomycin, ifosfamide (VAI), 2) Whole lung radiotherapy (Dirksen U, et al. J Clin Oncol. 2019 Dec 1;37(34):3192-3202. Le Deley MC, et al. J Clin Oncol. 2014 Aug 10;32(23):2440-8.)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C203561",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C203561",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203561",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C203561",
      "http://purl.obolibrary.org/obo/NCIT_C15538",
      "http://purl.obolibrary.org/obo/NCIT_C174447",
      "http://purl.obolibrary.org/obo/NCIT_C15787",
      "http://purl.obolibrary.org/obo/NCIT_C15320",
      "http://purl.obolibrary.org/obo/NCIT_C15429",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203583"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Sarcoma GX"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203583",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A sarcoma in which the grade cannot be evaluated."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C9023",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C9023",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C9023",
      "http://purl.obolibrary.org/obo/NCIT_C9118",
      "http://purl.obolibrary.org/obo/NCIT_C3810",
      "http://purl.obolibrary.org/obo/NCIT_C27574",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C7062"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C9023",
      "http://purl.obolibrary.org/obo/NCIT_C9118",
      "http://purl.obolibrary.org/obo/NCIT_C3810",
      "http://purl.obolibrary.org/obo/NCIT_C27574",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C7062"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203584"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Dental Care"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203584",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The maintenance of healthy teeth and gums through oral hygiene and dental care."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C15239",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C15239",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15239",
      "http://purl.obolibrary.org/obo/NCIT_C16205",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15239",
      "http://purl.obolibrary.org/obo/NCIT_C16205",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203585"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Vision Care"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203585",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The maintenance of eye health and visual acuity."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C15239",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C15239",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15239",
      "http://purl.obolibrary.org/obo/NCIT_C16205",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15239",
      "http://purl.obolibrary.org/obo/NCIT_C16205",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203586"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Spina Bifida Health Care Benefits Program"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203586",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Benefits provided by the Department of Veterans Affairs (VA) to certain Korea and Vietnam Veterans' birth children who have been diagnosed with spina bifida. It provides monetary allowances, vocational training and rehabilitation, and VA-financed health care benefits."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C157356",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C157356",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C157356",
      "http://purl.obolibrary.org/obo/NCIT_C16745",
      "http://purl.obolibrary.org/obo/NCIT_C115464",
      "http://purl.obolibrary.org/obo/NCIT_C19498",
      "http://purl.obolibrary.org/obo/NCIT_C25198",
      "http://purl.obolibrary.org/obo/NCIT_C20181",
      "http://purl.obolibrary.org/obo/NCIT_C97331"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C157356",
      "http://purl.obolibrary.org/obo/NCIT_C16745",
      "http://purl.obolibrary.org/obo/NCIT_C115464",
      "http://purl.obolibrary.org/obo/NCIT_C19498",
      "http://purl.obolibrary.org/obo/NCIT_C25198",
      "http://purl.obolibrary.org/obo/NCIT_C20181",
      "http://purl.obolibrary.org/obo/NCIT_C97331"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203587"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "FNCLCC Sarcoma Grade"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203587",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A grading system that refers to the evaluation of sarcomas according to the French Federation of Cancer Centers Sarcoma Group (FNCLCC) criteria."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C28076",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C28076",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C28076",
      "http://purl.obolibrary.org/obo/NCIT_C28099",
      "http://purl.obolibrary.org/obo/NCIT_C27992",
      "http://purl.obolibrary.org/obo/NCIT_C41009",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C28076",
      "http://purl.obolibrary.org/obo/NCIT_C28099",
      "http://purl.obolibrary.org/obo/NCIT_C27992",
      "http://purl.obolibrary.org/obo/NCIT_C41009",
      "http://purl.obolibrary.org/obo/NCIT_C20189"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203588"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Indian Health Care Program Services"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203588",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Health care services provided to American Indians and Alaska Natives (AI/ANs) at healthcare facilities run and funded directly by the Indian Health Service."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C15785",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C15785",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15785",
      "http://purl.obolibrary.org/obo/NCIT_C16205",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15785",
      "http://purl.obolibrary.org/obo/NCIT_C16205",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203589"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Indian Health Care Contracted Services"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203589",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Health care services provided to American Indians and Alaska Natives (AI/ANs) at healthcare facilities that are funded through contracts paid by the Indian Health Service."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C15785",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C15785",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15785",
      "http://purl.obolibrary.org/obo/NCIT_C16205",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15785",
      "http://purl.obolibrary.org/obo/NCIT_C16205",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C20359"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "TOPBP1 Gene"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C20359",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "This gene is involved in DNA replication and apoptosis regulation."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C19676",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C19676",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C19676",
      "http://purl.obolibrary.org/obo/NCIT_C16612"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C19676",
      "http://purl.obolibrary.org/obo/NCIT_C16612"
    ],
    "hasDirectChildren": true,
    "numDescendants": 1,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 1,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203590"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Indian Managed Care Entity"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203590",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A managed care organization (MCO), pre-paid inpatient health plan (PIHP), pre-paid ambulatory health plan (PAHP), primary care case management (PCCM) plan, or PCCM entity that is controlled by the Indian Health Service, a Tribe, Tribal Organization, or Urban Indian Organization, or consortium."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C15364",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C15364",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15364",
      "http://purl.obolibrary.org/obo/NCIT_C15239",
      "http://purl.obolibrary.org/obo/NCIT_C16205",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C15364",
      "http://purl.obolibrary.org/obo/NCIT_C15239",
      "http://purl.obolibrary.org/obo/NCIT_C16205",
      "http://purl.obolibrary.org/obo/NCIT_C16203",
      "http://purl.obolibrary.org/obo/NCIT_C43431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203591"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Tribally-Sponsored Health Insurance Program"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203591",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Private health insurance coverage purchased by tribal consortia to provide health care coverage in addition to those provided for Indian Health Service beneficiaries."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C204746",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C204746",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C204746",
      "http://purl.obolibrary.org/obo/NCIT_C157356",
      "http://purl.obolibrary.org/obo/NCIT_C16745",
      "http://purl.obolibrary.org/obo/NCIT_C115464",
      "http://purl.obolibrary.org/obo/NCIT_C19498",
      "http://purl.obolibrary.org/obo/NCIT_C25198",
      "http://purl.obolibrary.org/obo/NCIT_C20181",
      "http://purl.obolibrary.org/obo/NCIT_C97331"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C204746",
      "http://purl.obolibrary.org/obo/NCIT_C157356",
      "http://purl.obolibrary.org/obo/NCIT_C16745",
      "http://purl.obolibrary.org/obo/NCIT_C115464",
      "http://purl.obolibrary.org/obo/NCIT_C19498",
      "http://purl.obolibrary.org/obo/NCIT_C25198",
      "http://purl.obolibrary.org/obo/NCIT_C20181",
      "http://purl.obolibrary.org/obo/NCIT_C97331"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C203592"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Title V Mother and Child Health Block Grant"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C203592",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A program authorized under Title V of the Social Security Act to ensure the health and well-being of women, mothers, infants, children (including children with special health care needs), adolescents and their families. It is provided by funds given to states by the federal government."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C93390",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C93390",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C93390",
      "http://purl.obolibrary.org/obo/NCIT_C20020",
      "http://purl.obolibrary.org/obo/NCIT_C18820",
      "http://purl.obolibrary.org/obo/NCIT_C17769",
      "http://purl.obolibrary.org/obo/NCIT_C20181"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C93390",
      "http://purl.obolibrary.org/obo/NCIT_C20020",
      "http://purl.obolibrary.org/obo/NCIT_C18820",
      "http://purl.obolibrary.org/obo/NCIT_C17769",
      "http://purl.obolibrary.org/obo/NCIT_C20181"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  }
]